SACRAMENTO, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MELANOMA TISSUE BANK CONSORTIUM, founded in 2013, is a small nonprofit in the Diseases & Disorders sector that reported $321K in total revenue in fiscal year 2025. Revenue fell 36% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $98K, a strong 31% operating margin.
MELANOMA TISSUE BANK CONSORTIUM WAS CREATED TO PROVIDE TISSUE FOR FUNDAMENTAL PUBLIC AND PRIVATE RESEARCH.
IN 2025, MELANOMA TISSUE BANK CONSORTIUM (MTBC) RECEIVED $295,000 IN FUNDING FROM AIM AT MELANOMA. AIM AT MELANOMA IS A NOT-FOR-PROFIT ORGANIZATION THAT HAS TAKEN THE LEAD TO POOL RESOURCES IN ORDER...
IN 2025, MELANOMA TISSUE BANK CONSORTIUM (MTBC) RECEIVED $295,000 IN FUNDING FROM AIM AT MELANOMA. AIM AT MELANOMA IS A NOT-FOR-PROFIT ORGANIZATION THAT HAS TAKEN THE LEAD TO POOL RESOURCES IN ORDER TO FUND THIS INSTITUTION. IN 2025, THREE OF THE FOUR U.S. SITES CONTINUED TO COLLECT TISSUE, BLOOD, AND ANONYMIZED DATA. TWO SITES TRANSITIONED RESEARCH TEAMS AND PAUSED COLLECTION FOR AT LEAST PART OF THE YEAR. THE SITES COLLECTED A TOTAL OF 24 TISSUES IN 2025. ALSO IN 2025, DISCUSSIONS AND PRELIMINARY NEXT STEPS CONTINUED TO TAKE PLACE IN ORDER TO OPEN THE TWO SITES OF THE TISSUE BANK IN AUSTRALIA AND TO START COLLECTING TISSUE THERE. MTBC ANTICIPATES GRANTING SIGNIFICANT FUNDING TO CONTINUE COLLECTING TISSUE SAMPLES AT ALL FOUR US SITES AS WELL AS FOR OPENING TWO SITES IN AUSTRALIA.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $321,187 | $498,552 | -0.4% |
| Expenses | $222,720 | $273,625 | -0.2% |
| Net Income | $98,467 | $224,927 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| SAMANTHA GUILD | PRESIDENT | 8.00 |
Officer
Director
|
$0 | $0 | $0 |
| STEPHEN A SULLIVAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ALICIA OBERMAN | SECT/TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $321,187 | $222,720 | $2,043,699 | $98,467 |
| 2024 | $498,552 | $273,625 | $1,945,232 | $224,927 |
| 2023 | $596,164 | $244,903 | $1,720,305 | $351,261 |
| 2022 | $250,385 | $243,273 | $1,369,044 | $7,112 |
| 2021 | $275,379 | $24,150 | $1,361,932 | $251,229 |
| 2020 | $108,242 | $116,494 | $1,160,703 | $-8,252 |
| 2019 | $234,000 | $20,453 | $1,168,955 | $213,547 |
| 2018 | $285,000 | $47,268 | $955,408 | $237,732 |
Compare MELANOMA TISSUE BANK CONSORTIUM with other nonprofits in California and across the country.